Weekly Investment Analysts’ Ratings Changes for Watson Pharmaceuticals Incorporated (WPI

A number of stock research firms have changed their ratings and price targets for Watson Pharmaceuticals Incorporated (NYSE: WPI) during the last seven days:Watson Pharmaceuticals Incorporated had its “overweight” rating re-affirmed by analysts at Piper Jaffray. They now have a $78.00 price target on the stock.Watson Pharmaceuticals Incorporated had its “buy” rating re-affirmed by analysts at Canaccord Genuity.Watson Pharmaceuticals Incorporated had its price target lowered by analysts at Piper Jaffray from $78.00 to $73.00.Watson Pharmaceuticals Incorporated had its “buy” rating re-affirmed by analysts at UBS AG.Watson Pharmaceuticals Incorporated had its “hold” rating re-affirmed by analysts at Needham & Company.Watson Pharmaceuticals Incorporated ‘s EPS estimates were cut by analysts at Credit Suisse. They now have an “outperform” rating and a $77.00 price target on the stock.Watson Pharmaceuticals Incorporated had its “conviction buy” rating re-affirmed by analysts at Goldman Sachs.Watson Pharmaceuticals Incorporated was downgraded by analysts at Citigroup from a “buy” rating to a “neutral” rating.Watson Pharmaceuticals Incorporated was downgraded by analysts at Cowen from an “outperform” rating to a “neutral” rating.Watson Pharmaceuticals Incorporated was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $65.00 price target on the stock.Watson Pharmaceuticals Incorporated had its price target lowered by analysts at Collins Stewart from $75.00 to $60.00. They now have a “neutral” rating on the stock.Watson Pharmaceuticals Incorporated was upgraded by analysts at Bank of America to a “buy” rating.Watson Pharmaceuticals Incorporated was upgraded by analysts at RBC Capital from a “sector perform” rating to an “outperform” rating. They now have a $66.00 price target on the stock, down previously from $67.00.Watson Pharmaceuticals Incorporated had its price target lowered by analysts at Jefferies Group to $60.00.

No comments:

Post a Comment

Superhit News

News Archive